Using coronary computed tomography angiography (CCTA) with HeartFlow’s FFRCT Analysis to evaluate suspected coronary artery disease (CAD) offers more accurate non-invasive diagnosis, fewer unnecessary tests, and higher confidence in identifying patients needing treatment
November 07, 2022
Late-Breaking Data Demonstrate AHA/ACC Guideline-Directed CCTA ± FFRCT Precision Pathway is Superior to Traditional Testing
November 7, 2022 — HeartFlow, Inc., the leader in revolutionizing precision heartcare, today announced new trial…
Read More
A new analysis of iRhythm’s mSToPS trial, presented at the American Heart Association, reveals that Zio XT provided high value from a health economic perspective
November 07, 2022
New Research Confirms that Zio by iRhythm Provides High Value From a Health Economic Perspective
November 7, 2022 — iRhythm Technologies, Inc., a leading cardiovascular diagnostics and digital healthcare solutions…
Read More
Petr Ostadal, M.D., Ph.D., Professor of Medicine, Department of Cardiology, Na Homolce Hospital, Czech Republic. Image copyright Na Homolce Hospital
November 07, 2022
Early Use of ECMO devices Did Not Improve Outcomes in People With Cardiogenic Shock
November 7, 2022 — The immediate use of veno-arterial mechanical circulatory extracorporeal membrane oxygenation (ECMO…
Read More
Discover the key features of cardiovascular structured reporting that drive adoption, including automated data flow, EHR integration, and customizability.
November 07, 2022
Benefits of Cardiovascular Structured Reporting
Discover the key features of cardiovascular structured reporting that drive adoption, including automated data flow,…
Read More
New guidance covers recommendations for surgery, imaging, family screening, and the importance of a multidisciplinary team
November 05, 2022
AHA and ACC Issue New Guideline on Aortic Disease
Nov. 4, 2022 — The American College of Cardiology and the American Heart Association have published a new guideline on…
Read More
Study Advances Efforts to Launch CARDIALYTICS Suite of Analytic Tools
November 05, 2022
CathVision Announces Initiation of Clinical Study Evaluating Signal Complexity Algorithm
Nov. 4, 2022 — CathVision, a medical technology company developing innovative electrophysiology solutions to enhance…
Read More
The American Society of Nuclear Cardiology has issued an alert about possible supply disruptions
November 05, 2022
Alert: Mo-99/Tc-99m Supply Disruptions Possible
Nov. 4, 2022 — On October 28, the Nuclear Medicine Europe Emergency Response Team issued a statement about mechanical…
Read More
Late-breaking clinical presentations at VIVA show IN.PACT Admiral drug-coated PTA balloon catheter outperforms bare metal stents; maintains performance in real-world setting
November 03, 2022
Clinical Studies Show Medtronic Drug Coated Balloon Outperforms Bare Metal Stents; Maintains Performance in Real World
November 3, 2022 — Medtronic, a global leader in medical technology, today announced the results of two clinical…
Read More
A mouse heart with immune infiltrates leading to ICI-myocarditis. Image courtesy of UCSF
November 03, 2022
Study Sheds Light on the Reasons Behind Sex Differences in Myocarditis
November 3, 2022 — In the past several years, myocarditis has been of public interest because of cases associated with…
Read More
Fig. 1. Selective reduction of succinyl-CoA among the TCA cycle metabolites in cardiac muscle during chronic HF. Relative levels of the TCA cycle metabolites in cardiac muscles isolated from myocardial infarction (MI) mice, compared with those from sham mice, 28 d after surgery. Each data point in the dot plot represents one individual mouse sample (n = 38 for both groups for all metabolites, except for succinyl-CoA in which n = 18 for both groups). Concentrations of succinyl-CoA in these samples were 2.2–5
November 03, 2022
How Heart Failure Disrupts the Cell's Powerhouse
November 3, 2022 — Chronic heart failure causes the cell’s powerhouses to dysfunction, in part due to overconsumption…
Read More
About one-fifth of implants of left ventricular-assist devices have the complication of right heart failure. Abbott Laboratories (adapted)
November 02, 2022
Study Sifts Potential Factors of Device-Implant Complication
November 2, 2022 — For decades, left ventricular-assist devices (LVADs) have extended the lives of people whose hearts…
Read More
After mRNA vaccination, adults under 40 have a slightly greater chance of developing myocarditis or pericarditis, yet the vaccine’s benefits outweigh the risks, according to the American Journal of Preventive Medicine
November 02, 2022
Getting to the Heart of COVID-19 Vaccination and its Cardiovascular Risks
November 2, 2022 —  A comprehensive review and meta-analysis of published research confirm that young adults (40 years…
Read More
2D model showing how the pluripotent stem cells react to human relevant doses of cadmium over 8 days. From the control in the first panel, to the last panel, researchers can see how the differentiation to cardiomyocytes is inhibited with different doses of cadmium.
November 02, 2022
New 3D Model Shows How Cadmium Exposure May Affect Heart Development
November 2, 2022 —  Researchers have developed a three-dimensional model that shows how exposure to cadmium might lead…
Read More
November 02, 2022
VIVA Foundation Symposium presents Clinical Trial Findings
November 2, 2022 — The second round of late-breaking clinical trial results were announced at VIVA22 on Nov. 1 in Las…
Read More
November 02, 2022
The VEINS/VIVA 2022 Top Awards Recognize Leaders in Vascular Medicine
November 2, 2022 — A number of awards of distinction were presented during The VEINS (Venous Endovascular …
Read More
Deepak L. Bhatt, MD, MPH
November 01, 2022
Deepak L. Bhatt, MD, MPH, Named Director of Mount Sinai Heart
November 1, 2022 — Deepak L. Bhatt, MD, MPH, a top expert in cardiovascular medicine and interventional cardiology, has…
Read More
Proxy allows for seamless data transmission and improved AI-based plaque analysis
November 01, 2022
Cleerly Introduces Proxy Solution to Improve Heart Disease Imaging Workflows
November 1, 2022 — Cleerly, the company creating a new standard of care for heart disease, announced a new workflow…
Read More
Impella RP Flex with SmartAssist Illustration (Photo: Business Wire)
November 01, 2022
Impella RP Flex with SmartAssist Receives FDA Approval to Treat Right Heart Failure
November 1, 2022 —  Abiomed announced that Impella RP Flex with SmartAssist has received U.S. Food and Drug…
Read More
Johnson & Johnson to Acquire Abiomed
November 01, 2022
Johnson & Johnson to Acquire Abiomed
November 1, 2022 — Johnson & Johnson and Abiomed, a world leader in breakthrough heart, lung and kidney support…
Read More
DAIC's Top 10 for the month of October
By Melinda Taschetta-Millane
November 01, 2022
Top 10: What Viewers Were Reading in October
Here is what you and your colleagues found to be most interesting in the fields of diagnostic and interventional…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now